dr. john dipersio is his physician. he has a medical school's the division of oncology and also the deputy director of the university's affiliate of the cancer center at barnes and jewish hospital. >> and gina cola a of "the new york times". >> she reported as part of a ground breaking story on cancer research. i am pleased to have all of them at this table this evening. welcome. it is good to see you. tell me about the series and what went into it and what you were saying and what is the conclusions that are exciting for us to look at. >> my editors have this idea of calling it the genetic gamble which i thought was a fabulous way of describing it. because as you just said, this is really, researchers tell me this is the beginning, the forefront of a new era, they hope, in understanding diseases like cancer, and cancer is sort of the first one they are starting to study in this way. what they are trying to say, this is -- cancer is really a genetic disease, it is not necessarily like a disease of the breast of colon or

dr. john dipersio, one of dr. wartman's physicians. thank you for coming here. how do you feel?therwise, i feel generally pretty well. >> and about your future, you say it's unchartered waters. >> yeah. i grow more optimistic by the day, as i'm able to work more, get back in the swing of things, of doing the research that i do, and hopefully, i'll be seeing patients again soon. >> it's an extraordinary story of a man who has dedicated his life to cancer research. and in the very speciality that he has, he discovers that he has the disease. >> that's right. >> remarkable. and today, we find that, and it's a story of science, that science now offers possibilities that you might not have imagined when you began your medical studies, for sure. >> yeah, this technology wasn't available just ten years ago when i was finishing up medical school. >> tell me about genome sequencing and where it might be leading us in medicine. >> well, i think that it's still at the discovery phase, because we're not used to handling hundreds of millions of data points. so, normally, when you diagnose a